Home/Talphera/Vincent J. Angotti
VJ

Vincent J. Angotti

Chief Executive Officer

Talphera

Talphera Pipeline

DrugIndicationPhase
Niyad™ (nafamostat mesylate)Anticoagulation of the extracorporeal circuit for Continuous Renal Replacement Therapy (CRRT) and Intermittent Hemodialysis (IHD)Phase 3
LTX-608™ (nafamostat)Various inflammatory/viral indications (e.g., COVID-19, Disseminated Intravascular Coagulation (DIC), Acute Respiratory Distress Syndrome (ARDS), Acute Pancreatitis)Phase 3
Fedsyra™Ready-to-use pre-filled syringe of Ephedrine HydrochloridePhase 3
PFS-02Ready-to-use pre-filled syringe of Phenylephrine HydrochloridePhase 3